SCHEMBL3062001

SCHEMBL3062001

C=COC(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.46
RAB9A P51151 1/20 0.46
TSHR P16473 2/20 0.38
HTR3E A5X5Y0 1/20 0.38
GMNN O75496 1/20 0.38
HTR3B O95264 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
MTOR P42345 1/20 0.38
HTR3A P46098 1/20 0.38
PMP22 Q01453 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4243073 0.84 KDM4E (0.35) ALDH1A1GAAPOLB
SCHEMBL1018324 0.81 PARP1 (0.52) RAB9ATSHRALOX15MAPTKMT2A
SCHEMBL7974736 0.80 HCAR2 (0.55)
SCHEMBL2538499 0.79 CES2 (0.48) RAB9ATSHRALOX15MEN1MAPT
SCHEMBL6965570 0.78 TPMT (0.54) TPMTRAB9ATSHRHTR3EGMNN
SCHEMBL4239126 0.77 POLB (0.40) TPMTTSHRCYP1A2ALOX15HSD17B10
Acetic Acid SCHEMBL27803028 0.76 PARP1 (0.46) CYP1A2CYP2D6ALOX15MEN1MAPT
SCHEMBL25246032 0.75 POLB (0.55) HSD17B10MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL26965117 0.75 TPMT (0.46) TPMTRAB9AHTR3EHTR3BCYP1A2
SCHEMBL295796 0.75 ALDH1A1 (0.40) TSHRMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120251927-A1 HOLOGRAM-RECORDING MEDIUM KABUSHIKI KAISHA TOSHIBA (JP) 2012-10-04 US disclosed
EP-1939686-B1 Holographic recording medium TOSHIBA KK (JP) 2010-11-17 EP disclosed
US-20100221646-A1 HOLOGRAPHIC RECORDING MEDIUM KABUSHIKI KAISHA TOSHIBA (JP) 2010-09-02 US disclosed
US-7601465-B2 Holographic recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2009-10-13 US disclosed
US-20090226822-A1 RECORDING MEDIUM KABUSHIKI KAISHA TOSHIBA 2009-09-10 US disclosed
US-20090053616-A1 HOLOGRAPHIC RECORDING MEDIUM KABUSHIKI KAISHA TOSHIBA 2009-02-26 US disclosed
EP-1939686-A1 Holographic recording medium Kabushiki Kaisha Toshiba (JP) 2008-07-02 EP disclosed
US-20080145766-A1 Holographic recording medium KABUSHIKI KAISHA TOSHIBA 2008-06-19 US disclosed
US-20070224541-A1 Holographic recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2007-09-27 US disclosed
US-20070072089-A1 Holographic recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2007-03-29 US disclosed
US-20070065624-A1 Optical recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2007-03-22 US disclosed
US-20070030541-A1 Holographic recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2007-02-08 US disclosed
US-7095536-B2 Holographic recording medium and holographic recording medium manufacturing method KABUSHIKI KAISHA TOSHIBA (JP) 2006-08-22 US disclosed
US-20060126141-A1 Holographic recording medium and holographic recording medium manufacturing method KABUSHIKI KAISHA TOSHIBA (JP) 2006-06-15 US disclosed
US-20060115740-A1 Hologram recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2006-06-01 US disclosed
US-7031037-B2 Holographic recording medium and holographic recording medium manufacturing method KABUSHIKI KAISHA TOSHIBA (JP) 2006-04-18 US disclosed
US-20050018260-A1 Holographic recording medium and holographic recording medium manufacturing method KABUSHIKI KAISHA TOSHIBA (JP) 2005-01-27 US disclosed
US-20040180266-A1 Optical recording medium and method of manufacturing optical recording medium KABUSHIKI KAISHA TOSHIBA 2004-09-16 US disclosed
US-6165648-A Holographic recording LUCENT TECHNOLOGIES INC. (US) 2000-12-26 US disclosed
US-5874187-A Photo recording medium LUCENT TECHNOLOGIES INCORPORATED (US) 1999-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120251927-A1 HOLOGRAM-RECORDING MEDIUM TERT, TELO2, DNMT3A TPMT 225/4885RAB9A 1011/4885TSHR 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.